BusinessNewsAPI
Exclusive | Lilly Agrees to Buys Trio of Vaccine Developers - WSJ
Overview
Eli Lilly has agreed to acquire three vaccine developers, marking a significant expansion of its biologics and vaccine capabilities through targeted deals. The move complements Lilly’s recent acquisition of cell therapy group Kelonia and underscores a broader corporate push into high-priority biologics areas beyond metabolic drugs. This cluster of deals suggests Lilly is rapidly building external expertise in vaccines, cell therapies and related manufacturing to diversify its pipeline and platform strengths.
Entities
ORGThe Wall Street JournalORGEli Lilly
Relationship Graph
Click a connection line between nodes to view confidence and evidence.
Nodes: 2 · Connections: 1
Caused by
Led to
Related to
Same event
Press enter or space to select a node. You can then use the arrow keys to move the node around. Press delete to remove it and escape to cancel.
Press enter or space to select an edge. You can then press delete to remove it or escape to cancel.
Click a connection for evidence · click a node to open it
Select a connection to see why these events are linked.